Vertex Pharmaceuticals Incorporated | TalkMarkets

Latest Posts

Markets In A Minute - "A Lack Of Further Progress"

Article By: David Templeton

Tuesday, May 7, 2024 8:40 PM EDT

May's FOMC meeting left the Fed Funds Rate unchanged. JOLTS showed fewer job openings with increased layoffs. April's job report disappointed, adding only 175k jobs and seeing higher unemployment. Consumer confidence sharply dropped to 97 in April.

In this article: AMD, DIS, MCD, O, SPG, YUM, AAPL, AMZN, MCHP, NXPI, QCOM, VRTX, ANET, ON, UBER, ABNB, DUK, SBUX

Read

Vertex Pharmaceuticals (VRTX) Should Remain Supported

Article By: Elliottwave Forecast

Tuesday, February 27, 2024 5:11 AM EDT

Vertex Pharmaceuticals Incorporated (VRTX), is a biotechnology company. It engages in developing & commercializing therapies for treating cystic fibrosis (CF).

In this article: VRTX

Read

Biotech And Medtech Portfolio Notes On A Fed Day

Article By: Rod Raynovich

Wednesday, January 31, 2024 10:00 PM EDT

The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23%

In this article: BDX, BSX, EW, PFE, SYK, TMO, QQQ, VRTX, IHI, XBI, ARKG

Read

Biotech And Healthcare Portfolio Playbook For December 2023/24

Article By: Rod Raynovich

Monday, November 27, 2023 12:47 PM EDT

We are having a great but choppy market recovery over the past four weeks and it looks like it should continue through to the next earnings cycle in January.